Velabs Therapeutics announces strategic partnership with alytas therapeutics to develop a novel immune-based therapy for obesity Velabs Therapeutics announces strategic partnership with alytas therapeutics to develop a novel immune-based therapy for obesity September 3, 2019 General Read more
